跳至主要内容
临床试验/NCT03319602
NCT03319602已完成不适用

Effect of a Double Trunk Mask Associated to Nasal Prongs During a High Flow Oxygenation Method

Laboratory of Movement, Condorcet, Tournai, Belgium2 个研究点 分布在 1 个国家目标入组 15 人开始时间: 2017年2月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
15
试验地点
2
主要终点
Level of blood oxygenation (PaO2) after adjunction of a double trunk mask to a high flow oxygen canulae

研究概览

简要总结

The aim of this study is to determine the effect (on PaO2) of a modified mask associated to nasal cannula used for high flow oxygenation.

详细描述

Study Design This is a single-center, randomized, blind investigator, 2-way crossover study design. Enrolled participants had severe hypoxia being treated at Intensive Care Unit associated with a hospital in Hornu (Epicura).

The study consisted of two intervention periods of 2 weeks separated by a washout period of 20 minutes. (Figure 1) The objective of the study is to determine whether adjunctive mask of our design (Double Trunk Mask - DTM) has an effect on increasing arterial pressure in Oxygen (PaO2) diagnosed with severe hypoxia.

The protocol and informed consent documents were reviewed and approved by a recognized ethics review board at the study facility. The study was performed in accordance with the Declaration of Helsinki.

Statistical Analysis

All participants who received this intervention and completed two phases of study were included in the efficacy analysis.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Crossover
主要目的
Treatment
盲法
Single (Outcomes Assessor)

盲法说明

Assessor blind

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Regardless of gender, at least 18 years of age and diagnosed with severe Hypoxia (PaO2/FiO2 < 300 mm Hg), dyspnea with severe rest at stake accessory muscles of respiration, respiratory rate (RR) ≥ 25 CPM, PaCO2 ≤ 45 mmHg, patient with an arterial catheter and without hemodynamic instability, Glasgow Coma Scale ≥ 12/15, written consent. Participants were also required to have a sufficient level of education to understand study procedures and be able to communicate with site personnel.

排除标准

  • Patients were excluded if they Hypercapnia (> 45 mm Hg with respiratory acidosis), cardiogenic pulmonary edema, COPD, pulmonary fibrosis, hypoventilation obesity syndrom, arterial pressure < 60 mm Hg or treatment by epinephrine > to 0,1 gamma/kg/minute, deterioration of awareness (Glasgow scale < or = 12), acute confusional state.
  • Participants were randomized in a 1:1 ratio to receive either (CHFONP) classical High Flow Oxygenation with nasal prongs (20 minutes) or CHFNOP with an adjunctive of a DTM.

研究组 & 干预措施

Oxygenation only with nasal canula

Active Comparator

intervention: classical oxygenation with nasal canula (High flow)

干预措施: Double trunk mask add above a nasal canulae (Device)

Oxygenation with double trunk masknasal canula

Experimental

oxygenationwith DTM above nasal canula

干预措施: Double trunk mask add above a nasal canulae (Device)

结局指标

主要结局

Level of blood oxygenation (PaO2) after adjunction of a double trunk mask to a high flow oxygen canulae

时间窗: 4 hours

The primary endpoint was the change of PaO2. Sequence (Figure 1): The patient should be placed in semi-seated (position at 45 °) Patient will be oxygenated with high-fow nasal cannula (HFNC). Fraction delivered in Oxygen and flow rate will be adjusted to obtain a Saturation in oxygen \> at 90%. 1. Arterial gazometry will be taken after 20 and 60 minutes wih HFNC. 2. The clinician will associate the Double Trunk Mask (DTM) with the same parameters of the high-fow nasal cannula. Arterial gazometry will be performed after 20 and 60 minutes after placement of DTM. 3. After the withdrawal of DTM, arterial gazometry will be performed after 20 and 60 minutes

次要结局

未报告次要终点

研究者

发起方
Laboratory of Movement, Condorcet, Tournai, Belgium
申办方类型
Other
责任方
Principal Investigator
主要研究者

frédéric Duprez

Research collaborator

Laboratory of Movement, Condorcet, Tournai, Belgium

研究点 (2)

Loading locations...

相似试验

Effect of a Modified Oxygen Mask Associated to Nasal... | 临床试验